Nicotinamide–2,2,2-trifluoroethanol (2/1)
暂无分享,去创建一个
Alan R. Kennedy | Julie Bardin | Li Ven Wong | Blair F. Johnston | Alastair J. Florence | A. Florence | B. Johnston | A. Kennedy | J. Bardin | L. Wong
[1] J. McMahon,et al. Crystal engineering of the composition of pharmaceutical phases. , 2003, Chemical communications.
[2] Anthony L. Spek,et al. Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.
[3] K. Shankland,et al. Indexing powder patterns in physical form screening: instrumentation and data quality. , 2003, Journal of pharmaceutical sciences.
[4] Miwa,et al. Experimental charge density and electrostatic potential in nicotinamide. , 1999, Acta crystallographica. Section B, Structural science.
[5] Margaret C. Etter,et al. Encoding and decoding hydrogen-bond patterns of organic compounds , 1990 .
[6] T. Hino,et al. Assessment of nicotinamide polymorphs by differential scanning calorimetry , 2001 .
[7] S. Natarajan,et al. Bis(nicotinamidium) bis[(2R,3R)‐tartrate] 1.25‐hydrate: cations incorporated into hydrogen‐bonded arrays of anions and water molecules , 2007 .
[8] Robin Taylor,et al. Mercury: visualization and analysis of crystal structures , 2006 .
[9] S. Natarajan,et al. 3‐(Aminocarbonyl)pyridinium trifluoroacetate , 2007 .
[10] C. C. Seaton,et al. Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical Ingredients , 2008 .
[11] W. B. Wright,et al. The crystal structure of nicotinamide , 1954 .
[12] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.